$21.23
0.03 | 0.14%
0.03 | 0.14%
Today's Range:
21.13 -
21.35
IPXL Avg. Daily Volume:
489,400
05/25/12 - 4:00 PM ET
TRADE NOW
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 21.23 |
| 52 Week High | 27.07 |
| 52 Week Low | 14.46 |
| Avg. Daily Vol. (Mil) | 0.48 |
| Beta (3 year) | 0.99 |
| Share Related Items | |
| Mkt Cap (Mil) | 1,422.58 |
| Shares Out (Mil) | 67.01 |
| Float (Mil) | 62.28 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.90 |
| Current Ratio | 2.70 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 22.30 |
| Price/Sales | 2.67 |
| Price/Book | 2.27 |
| Price/Cash Flow | 17.30 |
| Per Share Data | |
| Earnings | 0.95 |
| Sales | 7.95 |
| Book Value | 9.35 |
| Cash Flow | 1.23 |
| Business Summary | |
|---|---|
| Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company focused on the development and commercialization of bioequivalent and brand-name pharmaceuticals, utilizing its controlled-release and other in-house development. | |
| General Information | |
| 30831 Huntwood Avenue
Hayward, CA 94544 |
|
| www.impaxlabs.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 1002 | |
| CEO: Dr. Larry Hsu,PhD | |
| Short Interest | |
| Current Month (Mil) | 3.34 |
| Previous Month (Mil) | 3.29 |
| Short Interest Ratio (Days) | 7.30 |
| Management Effectiveness | |
| Return on Equity | 10.20 |
| Return on Assets | 7.10 |
| Return on Investments | 10.20 |
| Profitability | |
| Gross Margin | 52.70 |
| EBIT Margin | 18.00 |
| Profit Margin | 12.00 |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
107.26
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet